Circl Brain Health Metrics

Circl operates at the intersection of neurotechnology, digital health, wearable computing, and B2B SaaS. Its proposed differentiation is the combination of short-session mobile EEG measurement with recurring software subscriptions and organizational reporting, rather than a consumer wellness product focused only on one-time scores. The company describes a subscription price of $360 per user per year and targets senior-living facilities and first responders, two segments where monitoring cognitive trends may have operational value. Its product set spans the Circl Mobile EEG Headset and App, a Brain Health Analytics and Reporting Platform, and a proactive brain-health management service. The available comparison set does not provide reliable named competitors, so Circl cannot be positioned precisely against specific companies without introducing unsupported claims. In practical terms, it competes for attention with broader digital therapeutics, remote patient monitoring, cognitive assessment, and wearable-neuroscience providers. Its potential advantage is the attempt to connect EEG-derived metrics to personalized behavioral recommendations and multi-user organizational workflows. Its main market constraints are early commercial scale, limited disclosed customer evidence, and the need to demonstrate that brain-health signals translate into repeatable outcomes for institutional buyers. The $676,634 disclosed funding base and two-person featured team indicate an early-stage position rather than an established category leader.

Circl’s trajectory shows a transition from formation and technical development toward early commercial validation. The company was founded on Apr 27, 2021 and raised $196,218 in its first disclosed pre-seed round on Aug 29, 2021. A further $126,603 followed on May 31, 2022, and the largest documented round, $353,813, closed on Sep 9, 2024. Together, these rounds total $676,634. Product development is centered on a mobile EEG headset and app, analytics software that generates brain-health scores, and a subscription service for ongoing monitoring and recommendations. The company reports $42,000 in sales to date, $277,000 in projected 2025 revenue, and $518,000 in active deals, suggesting that the principal inflection point is converting pilots and pipeline opportunities into recurring institutional revenue. Its stated $360-per-user annual subscription model provides a clear route to expansion if deployments in senior living and first-responder organizations become repeatable. However, available growth signals do not include hiring activity, employee-growth history, or disclosed customer counts. The featured team consists of CEO Dr Nolan Beise and CTO Paul Hill, while the employee range remains 11–50. As of Oct 7, 2026, the record supports an early commercialization narrative, but not evidence of scaled revenue or rapid workforce expansion.